Thursday, July 21, 2011

Omni Bio Pharmaceutical, Inc. (OMBP) Purchases 25% of BioMimetix for $2 Million

Omni Bio Pharmaceutical Inc. is an emerging biopharmaceutical company that has licensed therapies currently in development that have the potential to address large, unmet diseases and generate substantial commercialization potential. The company’s core strategy centers around licensing issued and pending patents that cover new uses for an existing FDA-approved drug.

The company today announced that it has acquired a 25 percent equity ownership of BioMimetix Inc. for $2 million in cash. In addition to this initial stake, Omni Bio was issued a common stock purchase warrant to acquire up to an additional 15 percent equity ownership interest in BioMimetix for an additional $2 million.

Concurrent with this investment, Duke University entered into an exclusive licensing agreement with BioMimetix. This firm is a recently formed biopharmaceutical company which intends to develop a new class of patented compounds for the treatment of various disease and health care treatment classifications including radiation toxicity incurred during cancer treatments.

The American Society for Radiation Oncology estimates that approximately 1 million patients undergo radiation therapy treatments annually in the United States. Therefore, based on what Omni Bio believes are conservative pricing estimates of $5,000 per patient for radio-protective drug treatment, the total addressable market in the United States could be as high as $5 billion. Add in the markets of Europe, Japan and Australia and that is another $5 billion.

For more information on Omni Bio Pharmaceutical, please visit the company’s website at www.omnibiopharma.com.

About QualityStocks:

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: